Correlation Between Propanc Biopharma and Sonnet Biotherapeutics

Can any of the company-specific risk be diversified away by investing in both Propanc Biopharma and Sonnet Biotherapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Propanc Biopharma and Sonnet Biotherapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Propanc Biopharma and Sonnet Biotherapeutics Holdings, you can compare the effects of market volatilities on Propanc Biopharma and Sonnet Biotherapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Propanc Biopharma with a short position of Sonnet Biotherapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Propanc Biopharma and Sonnet Biotherapeutics.

Diversification Opportunities for Propanc Biopharma and Sonnet Biotherapeutics

0.0

Correlation Coefficient

Propanc Biopharma  Sonnet Biotherapeutics

Pay attention - limited upside

The 3 months correlation between Propanc and Sonnet is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Propanc Biopharma and Sonnet Biotherapeutics Holding in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Sonnet Biotherapeutics and Propanc Biopharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Propanc Biopharma are associated (or correlated) with Sonnet Biotherapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Sonnet Biotherapeutics has no effect on the direction of Propanc Biopharma i.e., Propanc Biopharma and Sonnet Biotherapeutics go up and down completely randomly.

Pair Corralation between Propanc Biopharma and Sonnet Biotherapeutics

If you would invest (100.00) in Propanc Biopharma on September 13, 2024 and sell it today you would earn a total of  100.00  from holding Propanc Biopharma or generate -100.0% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Flat
Strength	Insignificant
Accuracy	0.0%
Values	Daily Returns

Propanc Biopharma  vs.  Sonnet Biotherapeutics Holding

Propanc Biopharma

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Propanc Biopharma has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of rather sound fundamental drivers, Propanc Biopharma is not utilizing all of its potentials. The latest stock price tumult, may contribute to shorter-term losses for the shareholders.

Sonnet Biotherapeutics

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Sonnet Biotherapeutics Holdings has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of inconsistent performance in the last few months, the Stock's basic indicators remain very healthy which may send shares a bit higher in January 2025. The recent disarray may also be a sign of long period up-swing for the firm investors.

Pair Trading with Propanc Biopharma and Sonnet Biotherapeutics

The main advantage of trading using opposite Propanc Biopharma and Sonnet Biotherapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Propanc Biopharma position performs unexpectedly, Sonnet Biotherapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Sonnet Biotherapeutics will offset losses from the drop in Sonnet Biotherapeutics' long position.

The idea behind Propanc Biopharma and Sonnet Biotherapeutics Holdings pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Companies Directory module to evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals.